Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History.

Cenin DR, Naber SK, de Weerdt AC, Jenkins MA, Preen DB, Ee HC, O'Leary PC, Lansdorp-Vogelaar I.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):10-21. doi: 10.1158/1055-9965.EPI-18-1123. Epub 2019 Nov 20.

PMID:
31748260
2.

Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents.

Bajor M, Zych AO, Graczyk-Jarzynka A, Muchowicz A, Firczuk M, Trzeciak L, Gaj P, Domagala A, Siernicka M, Zagozdzon A, Siedlecki P, Kniotek M, O'Leary PC, Golab J, Zagozdzon R.

Br J Cancer. 2018 Oct;119(7):873-884. doi: 10.1038/s41416-018-0263-y. Epub 2018 Oct 5.

3.

Initial evaluation of thyroid dysfunction - Are simultaneous TSH and fT4 tests necessary?

Schneider C, Feller M, Bauer DC, Collet TH, da Costa BR, Auer R, Peeters RP, Brown SJ, Bremner AP, O'Leary PC, Feddema P, Leedman PJ, Aujesky D, Walsh JP, Rodondi N.

PLoS One. 2018 Apr 30;13(4):e0196631. doi: 10.1371/journal.pone.0196631. eCollection 2018.

4.

The log TSH-free T4 relationship in a community-based cohort is nonlinear and is influenced by age, smoking and thyroid peroxidase antibody status.

Brown SJ, Bremner AP, Hadlow NC, Feddema P, Leedman PJ, O'Leary PC, Walsh JP.

Clin Endocrinol (Oxf). 2016 Nov;85(5):789-796. doi: 10.1111/cen.13107. Epub 2016 Jun 19.

5.

High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.

van den Hurk K, Balint B, Toomey S, O'Leary PC, Unwin L, Sheahan K, McDermott EW, Murphy I, van den Oord JJ, Rafferty M, FitzGerald DM, Moran J, Cummins R, MacEneaney O, Kay EW, O'Brien CP, Finn SP, Heffron CC, Murphy M, Yela R, Power DG, Regan PJ, McDermott CM, O'Keeffe A, Orosz Z, Donnellan PP, Crown JP, Hennessy BT, Gallagher WM.

Melanoma Res. 2015 Jun;25(3):189-99. doi: 10.1097/CMR.0000000000000149.

PMID:
25746038
6.

Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer.

O'Leary PC, Terrile M, Bajor M, Gaj P, Hennessy BT, Mills GB, Zagozdzon A, O'Connor DP, Brennan DJ, Connor K, Li J, Gonzalez-Angulo AM, Sun HD, Pu JX, Pontén F, Uhlén M, Jirström K, Nowis DA, Crown JP, Zagozdzon R, Gallagher WM.

Breast Cancer Res. 2014 Jul 10;16(4):R79. doi: 10.1186/bcr3691.

7.

Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease.

Medici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, Rawal R, Roef GL, Plantinga TS, Vermeulen SH, Lahti J, Simmonds MJ, Husemoen LL, Freathy RM, Shields BM, Pietzner D, Nagy R, Broer L, Chaker L, Korevaar TI, Plia MG, Sala C, Völker U, Richards JB, Sweep FC, Gieger C, Corre T, Kajantie E, Thuesen B, Taes YE, Visser WE, Hattersley AT, Kratzsch J, Hamilton A, Li W, Homuth G, Lobina M, Mariotti S, Soranzo N, Cocca M, Nauck M, Spielhagen C, Ross A, Arnold A, van de Bunt M, Liyanarachchi S, Heier M, Grabe HJ, Masciullo C, Galesloot TE, Lim EM, Reischl E, Leedman PJ, Lai S, Delitala A, Bremner AP, Philips DI, Beilby JP, Mulas A, Vocale M, Abecasis G, Forsen T, James A, Widen E, Hui J, Prokisch H, Rietzschel EE, Palotie A, Feddema P, Fletcher SJ, Schramm K, Rotter JI, Kluttig A, Radke D, Traglia M, Surdulescu GL, He H, Franklyn JA, Tiller D, Vaidya B, de Meyer T, Jørgensen T, Eriksson JG, O'Leary PC, Wichmann E, Hermus AR, Psaty BM, Ittermann T, Hofman A, Bosi E, Schlessinger D, Wallaschofski H, Pirastu N, Aulchenko YS, de la Chapelle A, Netea-Maier RT, Gough SC, Meyer Zu Schwabedissen H, Frayling TM, Kaufman JM, Linneberg A, Räikkönen K, Smit JW, Kiemeney LA, Rivadeneira F, Uitterlinden AG, Walsh JP, Meisinger C, den Heijer M, Visser TJ, Spector TD, Wilson SG, Völzke H, Cappola A, Toniolo D, Sanna S, Naitza S, Peeters RP.

PLoS Genet. 2014 Feb 27;10(2):e1004123. doi: 10.1371/journal.pgen.1004123. eCollection 2014 Feb.

8.

Age-related changes in thyroid function: a longitudinal study of a community-based cohort.

Bremner AP, Feddema P, Leedman PJ, Brown SJ, Beilby JP, Lim EM, Wilson SG, O'Leary PC, Walsh JP.

J Clin Endocrinol Metab. 2012 May;97(5):1554-62. doi: 10.1210/jc.2011-3020. Epub 2012 Feb 16.

PMID:
22344200
9.

Significant association between thyroid hormones and erythrocyte indices in euthyroid subjects.

Bremner AP, Feddema P, Joske DJ, Leedman PJ, O'Leary PC, Olynyk JK, Walsh JP.

Clin Endocrinol (Oxf). 2012 Feb;76(2):304-11. doi: 10.1111/j.1365-2265.2011.04228.x.

PMID:
21913954
10.

Awakening Australia to Rare Diseases: symposium report and preliminary outcomes.

Dawkins HJ, Molster CM, Youngs LM, O'Leary PC.

Orphanet J Rare Dis. 2011 Aug 18;6:57. doi: 10.1186/1750-1172-6-57. No abstract available.

11.

Outcomes of a cystic fibrosis carrier testing clinic for couples.

O'Leary PC, Maxwell SJ, Youngs LM, Brameld KJ, Walpole IR.

Med J Aust. 2010 Feb 15;192(4):238; author reply 238-9. No abstract available.

PMID:
20170468
12.

Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study.

O'Leary PC, Feddema PH, Michelangeli VP, Leedman PJ, Chew GT, Knuiman M, Kaye J, Walsh JP.

Clin Endocrinol (Oxf). 2006 Jan;64(1):97-104.

PMID:
16402936
13.

Human gene patents: the possible impacts on genetic services healthcare.

Walpole IR, Dawkins HJ, Sinden PD, O'Leary PC.

Med J Aust. 2003 Aug 18;179(4):203.

PMID:
12914511
14.

Distribution and metabolism of topically applied progesterone in a rat model.

Waddell BJ, O'Leary PC.

J Steroid Biochem Mol Biol. 2002 Apr;80(4-5):449-55.

PMID:
11983492
15.

Therapeutic efficiency of tirofiban in acute coronary syndromes.

Burnett JR, Blennerhassett J, McConnell W, O'Leary PC, Vasikaran SD.

Lancet. 2000 Mar 11;355(9207):929-31. No abstract available.

PMID:
10752729
16.
17.

Measurement of fetal urinary sodium in obstructive uropathy: a question of units.

O'Leary PC, Newnham JP, Goldblatt J.

Am J Obstet Gynecol. 1996 Jul;175(1):229-31. No abstract available.

PMID:
8694058
18.

Effect of asthma treatment on urinary growth hormone excretion in children.

O'Leary PC, McIntyre E, Feddema P, LeSouëf PN.

Pediatr Pulmonol. 1996 Jun;21(6):361-6.

PMID:
8927462
19.

Elevated mid-trimester hCG and maternal lupus anticoagulant.

Clark F, Dickinson JE, Walters BN, Marshall LR, O'Leary PC.

Prenat Diagn. 1995 Nov;15(11):1035-9.

PMID:
8606882
20.
21.

Longitudinal study of serum thyroid hormone levels during normal pregnancy.

O'Leary PC, Boyne P, Atkinson G, Mileham KJ, James I.

Int J Gynaecol Obstet. 1992 Jul;38(3):171-9.

PMID:
1360418
22.

Inhibin secretion is influenced by Leydig cells: evidence from studies using the cytotoxin ethane dimethane sulphonate (EDS).

De Kretser DM, O'Leary PC, Irby DC, Risbridger GP.

Int J Androl. 1989 Aug;12(4):273-80.

PMID:
2553617
23.

Alterations in mitogenic and steroidogenic activities in rat testicular interstitial fluid after administration of ethane dimethane sulphonate.

Drummond AE, Risbridger GP, O'Leary PC, de Kretser DM.

J Reprod Fertil. 1988 May;83(1):141-7.

PMID:
2840493
24.

Effects of ethane dimethane sulphonate (EDS) on seminiferous tubule function in rats.

O'Leary PC, Jackson AE, Irby DC, de Kretser DM.

Int J Androl. 1987 Aug;10(4):625-34.

PMID:
2820886
25.
26.
27.

Indomethacin therapy and the measurement of urinary 5-hydroxyindoleacetic acid.

O'Leary PC, Edelman J, Riley WJ.

Clin Chim Acta. 1982 Dec 23;126(3):323-6. No abstract available.

PMID:
6185255

Supplemental Content

Loading ...
Support Center